Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Can COX-2 Inhibitor Decrease Stricture Recurrence After Direct Vision Internal Urethrotomy?

NCT06697106 is registered in ClinicalTrials.gov with New Valley University as lead sponsor.

NCT NCT06697106
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06697106 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Can COX-2 Inhibitor Decrease Stricture Recurrence After Direct Vision Internal Urethrotomy?
Lead sponsor
New Valley University
Phase
Not applicable
Overall status
Recruiting
Start date
November 20, 2024
Completion date
April 1, 2025
Enrollment
82 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cox-2 inhibitor, direct vision internal urethrotomy, meloxicam, stricture recurrence